175 related articles for article (PubMed ID: 19223461)
1. Fibroblast growth factor receptor 3 associates with and tyrosine phosphorylates p90 RSK2, leading to RSK2 activation that mediates hematopoietic transformation.
Kang S; Elf S; Dong S; Hitosugi T; Lythgoe K; Guo A; Ruan H; Lonial S; Khoury HJ; Williams IR; Lee BH; Roesel JL; Karsenty G; Hanauer A; Taunton J; Boggon TJ; Gu TL; Chen J
Mol Cell Biol; 2009 Apr; 29(8):2105-17. PubMed ID: 19223461
[TBL] [Abstract][Full Text] [Related]
2. FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway.
Kang S; Dong S; Gu TL; Guo A; Cohen MS; Lonial S; Khoury HJ; Fabbro D; Gilliland DG; Bergsagel PL; Taunton J; Polakiewicz RD; Chen J
Cancer Cell; 2007 Sep; 12(3):201-14. PubMed ID: 17785202
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529.
Kang S; Dong S; Guo A; Ruan H; Lonial S; Khoury HJ; Gu TL; Chen J
J Biol Chem; 2008 Feb; 283(8):4652-7. PubMed ID: 18156174
[TBL] [Abstract][Full Text] [Related]
4. New insights into RSK activation and hematopoietic cancer.
Cuadrado A; Nebreda AR
Cancer Cell; 2007 Sep; 12(3):187-9. PubMed ID: 17785199
[TBL] [Abstract][Full Text] [Related]
5. Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis.
Lee CJ; Moon SJ; Jeong JH; Lee S; Lee MH; Yoo SM; Lee HS; Kang HC; Lee JY; Lee WS; Lee HJ; Kim EK; Jhun JY; Cho ML; Min JK; Cho YY
Cell Death Dis; 2018 Mar; 9(3):401. PubMed ID: 29540697
[TBL] [Abstract][Full Text] [Related]
6. Constitutively activated FGFR3 mutants signal through PLCgamma-dependent and -independent pathways for hematopoietic transformation.
Chen J; Williams IR; Lee BH; Duclos N; Huntly BJ; Donoghue DJ; Gilliland DG
Blood; 2005 Jul; 106(1):328-37. PubMed ID: 15784730
[TBL] [Abstract][Full Text] [Related]
7. FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies.
Chen J; Lee BH; Williams IR; Kutok JL; Mitsiades CS; Duclos N; Cohen S; Adelsperger J; Okabe R; Coburn A; Moore S; Huntly BJ; Fabbro D; Anderson KC; Griffin JD; Gilliland DG
Oncogene; 2005 Dec; 24(56):8259-67. PubMed ID: 16091734
[TBL] [Abstract][Full Text] [Related]
8. RSK2 regulates endocytosis of FGF receptor 1 by phosphorylation on serine 789.
Nadratowska-Wesolowska B; Haugsten EM; Zakrzewska M; Jakimowicz P; Zhen Y; Pajdzik D; Wesche J; Wiedlocha A
Oncogene; 2014 Oct; 33(40):4823-36. PubMed ID: 24141780
[TBL] [Abstract][Full Text] [Related]
9. A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1.
Frödin M; Jensen CJ; Merienne K; Gammeltoft S
EMBO J; 2000 Jun; 19(12):2924-34. PubMed ID: 10856237
[TBL] [Abstract][Full Text] [Related]
10. p90 ribosomal S6 kinase 2 is associated with and dephosphorylated by protein phosphatase 2Cdelta.
Doehn U; Gammeltoft S; Shen SH; Jensen CJ
Biochem J; 2004 Sep; 382(Pt 2):425-31. PubMed ID: 15206906
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of caspase-8 (Thr-263) by ribosomal S6 kinase 2 (RSK2) mediates caspase-8 ubiquitination and stability.
Peng C; Cho YY; Zhu F; Zhang J; Wen W; Xu Y; Yao K; Ma WY; Bode AM; Dong Z
J Biol Chem; 2011 Mar; 286(9):6946-54. PubMed ID: 21183680
[TBL] [Abstract][Full Text] [Related]
12. The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells.
Li Z; Zhu YX; Plowright EE; Bergsagel PL; Chesi M; Patterson B; Hawley TS; Hawley RG; Stewart AK
Blood; 2001 Apr; 97(8):2413-9. PubMed ID: 11290605
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of FGFR3 by PTPN1 and PTPN2.
St-Germain JR; Taylor P; Zhang W; Li Z; Ketela T; Moffat J; Neel BG; Trudel S; Moran MF
Proteomics; 2015 Jan; 15(2-3):419-33. PubMed ID: 25311528
[TBL] [Abstract][Full Text] [Related]
14. RSK2 drives cell motility by serine phosphorylation of LARG and activation of Rho GTPases.
Shi GX; Yang WS; Jin L; Matter ML; Ramos JW
Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E190-E199. PubMed ID: 29279389
[TBL] [Abstract][Full Text] [Related]
15. The enigma of ectopic expression of FGFR3 in multiple myeloma: a critical initiating event or just a target for mutational activation during tumor progression.
Chesi M; Bergsagel PL; Kuehl WM
Curr Opin Hematol; 2002 Jul; 9(4):288-93. PubMed ID: 12042702
[TBL] [Abstract][Full Text] [Related]
16. The cytoplasmic tyrosine kinase Pyk2 as a novel effector of fibroblast growth factor receptor 3 activation.
Meyer AN; Gastwirt RF; Schlaepfer DD; Donoghue DJ
J Biol Chem; 2004 Jul; 279(27):28450-7. PubMed ID: 15105428
[TBL] [Abstract][Full Text] [Related]
17. 90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1.
Jensen CJ; Buch MB; Krag TO; Hemmings BA; Gammeltoft S; Frödin M
J Biol Chem; 1999 Sep; 274(38):27168-76. PubMed ID: 10480933
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
Roux PP; Richards SA; Blenis J
Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
[TBL] [Abstract][Full Text] [Related]
19. Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation.
Cho YY; Yao K; Kim HG; Kang BS; Zheng D; Bode AM; Dong Z
Cancer Res; 2007 Sep; 67(17):8104-12. PubMed ID: 17804722
[TBL] [Abstract][Full Text] [Related]
20. Kinase Activity of Fibroblast Growth Factor Receptor 3 Regulates Activity of the Papillomavirus E2 Protein.
Xie F; DeSmet M; Kanginakudru S; Jose L; Culleton SP; Gilson T; Li C; Androphy EJ
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
